MiniMed Reports Rise in 1st-Quarter Earnings
MiniMed Inc., a Sylmar maker of equipment used to treat diabetics, said its earnings in the first quarter that ended March 29 were $627,000 compared to a loss of $452,000 in the first quarter last year. The gain was on revenues of $12.2 million, up 47% from $8.3 million last year.
The company attributed the increase to wider acceptance of its devices, which are used in place of needles to provide diabetics with insulin.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
